ロード中...
Berberine Improves Chemo-Sensitivity to Cisplatin by Enhancing Cell Apoptosis and Repressing PI3K/AKT/mTOR Signaling Pathway in Gastric Cancer
Gastric cancer is one of the most common malignancies ranks as the second leading cause of cancer-related mortality in the world. Cisplatin (DDP) is commonly used for gastric cancer treatment, whereas recurrence and metastasis are common because of intrinsic and acquired DDP-resistance. The aim of t...
保存先:
| 出版年: | Front Pharmacol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7756080/ https://ncbi.nlm.nih.gov/pubmed/33362566 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.616251 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|